STADA, a global manufacturer known for its high-quality generic drugs and consumer healthcare products, recently announced its recent acquisition of an established OTC portfolio in the PH. The Company, FERN C is a well-established range of food supplements and STADA is positive that the acquisition will help them execute its growth ambitions in the Philippines. The official announcement was made last February 7, 2020 at at Shangri-La The Fort during the Stada and Fern C event entitled Expanding Health Horizon.
During the platform launch, STADA boasted of its long lasting history of selling pharmaceutical products into the Philippines formerly through Croma Medic Inc. which was required by STADA in [early 2000] and recently renamed into STADA Philippines. They also announced a number of acquisitions and partnerships in Europe recently and how they are also expanding its portfolio in the Asia-Pacific region.
With the acquisition, STADA now establish a strong consumer healthcare platform to launch other quality medicines as well and provide better health for all Filipinos. The FERN portfolio in the Philippines, it being one of the leading brands in the growing local Vitamin C in the market have product range that consists of FERN-C, a Vitamin C product that has been in the market for 15 years and FERN-C Kidz and Kiddimin – two products for the vitamin supply for children.
At the launch, STADA CEO Peter Goldschmidt stated that, “After having formally launched STADA Philippines, we are now fully enabled to execute our growth ambitions in this market as well. The acquisition of FERN will help us to succeed. The acquisition of these products is in line with our strategy to strengthen our portfolio with well-established consumer healthcare brands and also expand in selected emerging markets.”
While STADA Asia Pacific Managing Director Gary Clark declared, “STADA has been helping people by making high quality products. That is why STADA is always on the lookout for acquisitions and partnerships. With the acquisition of these established brands, it will further STADA’s vision to be a trusted partner that provides high-quality, holistic care for the people. With both STADA and FERN carrying heritage, we will be able to provide better health for Filipinos.“
Sharmaine Abarientos, General Manager of STADA Philippines, added: “FERN has not only an established brand heritage, but also a complete range for adults as well as for the pediatric application. With FERN in our portfolio, we will establish a strong consumer healthcare platform to launch other quality medicines as well and provide better health for all Filipinos. With our successful portfolio expansion activities, we are able to offer quality medicines at reasonable prices, across all segments of healthcare; specialty, generics and consumer health.”
Dr. Antonio Ligsay of St. Luke Medical Center College of Medicine also enlightened the audience of the importance of Vitamin C with regards to infection during the launch.
